Chemoinformaics analysis of APO-BETA-ERYTHROIDINE
| Molecular Weight | 241.29 | nRot | 0 |
| Heavy Atom Molecular Weight | 226.17 | nRig | 21 |
| Exact Molecular Weight | 241.11 | nRing | 4 |
| Solubility: LogS | -4.362 | nHRing | 3 |
| Solubility: LogP | 3.461 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 37.7559 |
| nHD | 0 | BPOL | 19.3621 |
| QED | 0.651 |
| Synth | 3.283 |
| Natural Product Likeliness | 0.634 |
| NR-PPAR-gamma | 0.818 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.991 |
| Pgp-sub | 0.004 |
| HIA | 0.007 |
| CACO-2 | -4.768 |
| MDCK | 0.0000311 |
| BBB | 0.331 |
| PPB | 0.945475 |
| VDSS | 1.002 |
| FU | 0.0486533 |
| CYP1A2-inh | 0.924 |
| CYP1A2-sub | 0.827 |
| CYP2c19-inh | 0.95 |
| CYP2c19-sub | 0.409 |
| CYP2c9-inh | 0.873 |
| CYP2c9-sub | 0.522 |
| CYP2d6-inh | 0.827 |
| CYP2d6-sub | 0.848 |
| CYP3a4-inh | 0.533 |
| CYP3a4-sub | 0.652 |
| CL | 5.648 |
| T12 | 0.214 |
| hERG | 0.349 |
| Ames | 0.898 |
| ROA | 0.696 |
| SkinSen | 0.903 |
| Carcinogencity | 0.78 |
| EI | 0.056 |
| Respiratory | 0.415 |
| NR-Aromatase | 0.126 |
| Antiviral | No |
| Prediction | 0.604951 |